A. Rao, C. Luo, and P. Hogan, Transcription factors of the NFAT family: regulation and function, Annu Rev Immunol, vol.15, pp.707-747, 1997.

C. E. Staatz and S. E. Tett, Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation, Clin. Pharmacokinet, pp.43-623, 2004.

M. Rodríguez-perálvarez, G. Germani, T. Darius, J. Lerut, E. Tsochatzis et al., Tacrolimus trough levels, rejection and renal impairment in liver transplantation: a systematic review and meta-analysis, Am. J. Transplant, vol.12, pp.2797-2814, 2012.

M. Naesens, D. R. Kuypers, and M. Sarwal, Calcineurin Inhibitor Nephrotoxicity, Clin. J. Am. Soc. Nephrol, vol.4, pp.481-508, 2009.

D. H. Mallon, D. M. Summers, J. A. Bradley, and G. J. Pettigrew, Defining delayed graft function after renal transplantation: simplest is best, Transplantation, pp.96-885, 2013.

B. Nashan, M. Abbud-filho, and F. Citterio, Prediction, prevention, and management of delayed graft function: where are we now?, Clin. Transplant, pp.30-1198, 2016.

P. A. Jacobson, D. Schladt, W. S. Oetting, R. Leduc, W. Guan et al., Lower calcineurin inhibitor doses in older compared to younger kidney transplant recipients yield similar troughs, Am. J. Transplant, pp.12-3326, 2012.

E. David-neto, P. Romano, K. Triboni, A. H. Ramos, F. Agena et al., Longitudinal Pharmacokinetics of Tacrolimus in Elderly Compared With Younger Recipients in the First 6 Months After Renal Transplantation, Transplantation, vol.101, pp.1365-1372, 2017.

K. A. Barraclough, C. E. Staatz, D. W. Johnson, K. J. Lee, B. C. Mcwhinney et al., Kidney transplant outcomes are related to tacrolimus, mycophenolic acid and prednisolone exposure in the first week, Transpl. Int, pp.25-1182, 2012.

D. R. Kuypers, H. De-jonge, M. Naesens, and Y. Vanrenterghem, A prospective, open-label, observational clinical cohort study of the association between delayed renal allograft function, tacrolimus exposure, and CYP3A5 genotype in adult recipients, Clin. Ther, pp.32-2012, 2010.

H. Ekberg, T. Van-gelder, B. Kaplan, and C. Bernasconi, Relationship of tacrolimus exposure and mycophenolate mofetil dose with renal function after renal transplantation, Transplantation, vol.92, pp.82-87, 2011.

M. A. Huaman, V. Vilchez, X. Mei, D. Davenport, and R. Gedaly, Donor positive blood culture is associated with delayed graft function in kidney transplant recipients: a propensity score analysis of the UNOS database, Clin. Transplant, vol.30, pp.415-420, 2016.

R. R. Redfield, J. R. Scalea, T. J. Zens, B. Muth, D. B. Kaufman et al., Predictors and outcomes of delayed graft function after living-donor kidney transplantation, Transpl. Int, vol.29, pp.81-87, 2016.

, Accepted Article

A. Andrés, K. Budde, P. Clavien, T. Becker, M. Kessler et al., A randomized trial comparing renal function in older kidney transplant patients following delayed versus immediate tacrolimus administration, Transplantation, vol.88, pp.1101-1108, 2009.

A. Sharif, S. Shabir, S. Chand, P. Cockwell, S. Ball et al., Meta-analysis of calcineurininhibitor-sparing regimens in kidney transplantation, J. Am. Soc. Nephrol, vol.22, pp.2107-2118, 2011.

K. A. Birdwell, B. Grady, L. Choi, H. Xu, A. Bian et al., The use of a DNA biobank linked to electronic medical records to characterize pharmacogenomic predictors of tacrolimus dose requirement in kidney transplant recipients, Pharmacogenet. Genomics, vol.22, pp.32-42, 2012.